Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

Does the cell number 109still really fit one gram of tumor tissue?

(2011) Ugo Del Monte   CELL CYCLE

Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes

(2010) J. N. Barker et al.   BLOOD

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

(2010) K. S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

(2009) J. Styczynski et al.   Transplant Infectious Disease

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT

(2008) S Ocheni et al.   BONE MARROW TRANSPLANTATION

Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

(2008) Ellen Meijer et al.   CURRENT OPINION IN HEMATOLOGY

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results

(2008) Anna Merlo et al.   EXPERT OPINION ON BIOLOGICAL THERAPY